From: ADHD medicine consumption in Europe after COVID-19: catch-up or trend change?
Substance | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|---|---|---|
AMFETAMINE | 0.020 | 0.022 | 0.032 | 0.037 | 0.042 | 0.060 | 0.089 | 0.105 | 0.120 |
ATOMOXETINE | 0.077 | 0.081 | 0.087 | 0.086 | 0.086 | 0.094 | 0.094 | 0.103 | 0.117 |
DEXMETHYLPHENIDATE | 0.006 | 0.007 | 0.007 | 0.008 | 0.008 | 0.008 | 0.009 | 0.010 | 0.011 |
GUANFACINE | 0.000 | 0.000 | 0.005 | 0.020 | 0.033 | 0.044 | 0.054 | 0.064 | 0.074 |
LISDEXAMFETAMINE | 0.066 | 0.142 | 0.209 | 0.259 | 0.312 | 0.392 | 0.488 | 0.602 | 0.773 |
METHYLPHENIDATE | 1.657 | 1.674 | 1.710 | 1.755 | 1.812 | 1.918 | 1.901 | 2.085 | 2.325 |